APA (7th ed.) Citation

AH, P., SJ, A., BC, L., L, F., CI, F., KM, K., . . . N, W. (2012). Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): A multicentre, placebo-controlled, randomised trial. The Lancet. Oncology, 13(7), 734. https://doi.org/10.1016/S1470-2045(12)70226-7

Chicago Style (17th ed.) Citation

AH, Paterson, et al. "Oral Clodronate for Adjuvant Treatment of Operable Breast Cancer (National Surgical Adjuvant Breast and Bowel Project Protocol B-34): A Multicentre, Placebo-controlled, Randomised Trial." The Lancet. Oncology 13, no. 7 (2012): 734. https://doi.org/10.1016/S1470-2045(12)70226-7.

MLA (9th ed.) Citation

AH, Paterson, et al. "Oral Clodronate for Adjuvant Treatment of Operable Breast Cancer (National Surgical Adjuvant Breast and Bowel Project Protocol B-34): A Multicentre, Placebo-controlled, Randomised Trial." The Lancet. Oncology, vol. 13, no. 7, 2012, p. 734, https://doi.org/10.1016/S1470-2045(12)70226-7.